How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Medical Device Testing Market
- By Device Type: Cardiovascular Devices, Orthopedic Devices, Diagnostic Imaging Devices, In Vitro Diagnostic Devices, Neurological Devices
- By Testing Type: Biocompatibility Testing, Electrical Safety Testing, Performance Testing, Sterilization Validation, Software Validation
- By End User: Medical Device Manufacturers, Contract Research Organizations (CROs), Hospitals and Clinics, Regulatory Bodies, Academic and Research Institutions
- By Testing Methodology: In Vitro Testing, In Vivo Testing, Mechanical Testing, Chemical Testing, Electrical Testing
- By Regulatory Compliance: FDA Compliance Testing, ISO 13485 Compliance Testing, CE Marking Testing, IEC 60601 Compliance Testing, ISO 10993 Compliance Testing
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Cardiovascular Devices leads By Device Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 310 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Medical Device Testing Market report
A complete, evidence-based study - 12 chapters and 130 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Device Type 5
Testing Type 5
End User 5
Testing Methodology 5
Regulatory Compliance 5
Companies profiled
Eurofins Scientific
SGS SA
Intertek Group plc
TÜV SÜD
Bureau Veritas
UL LLC
NSF International
Covance Inc. (LabCorp)
Charles River Laboratories International Inc.
Pace Analytical Services Inc.
Applus+ Laboratories
QPS Holdings
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Eurofins Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →SGS SA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Intertek Group plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →TÜV SÜD
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Bureau Veritas
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →UL LLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →NSF International
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Covance Inc. (LabCorp)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Charles River Laboratories International Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Pace Analytical Services Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Applus+ Laboratories
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →QPS Holdings
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →ICON plc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Parexel International Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Medpace Holdings
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,363M by 2033 · 9.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Cardiovascular Devices56.2
- Orthopedic Devices7.4
- Diagnostic Imaging Devices11.4
- In Vitro Diagnostic Devices11.0
- Neurological Devices13.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,023M → $2,110M · 9.5%
Europe$712.9M → $1,378M · 8.6%
Asia Pacific$650.9M → $1,323M · 9.3%
Latin America$402.9M → $901.6M · 10.6%
Middle East and Africa$310.0M → $567.7M · 7.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.352026
9.362027
9.392028
9.402029
9.412030
9.422031
9.442032
9.442033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Eurofins Scientific24.8
- SGS SA9.5
- Intertek Group plc13.3
- TÜV SÜD5.2
- Bureau Veritas7.7
- UL LLC11.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Device Type22.8%
Testing Type18.9%
End User26.5%
Testing Methodology19.6%
Regulatory Compliance12.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.6
- Europe21.9
- Asia Pacific21.1
- Latin America14.4
- Middle East and Africa9.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Eurofins Scientific | 74 | 77 | 81 | 83 | 82 | 85 | 80 |
| SGS SA | 92 | 69 | 74 | 74 | 70 | 71 | 75 |
| Intertek Group plc | 88 | 65 | 68 | 67 | 73 | 76 | 73 |
| TÜV SÜD | 57 | 70 | 72 | 70 | 74 | 70 | 69 |
| Bureau Veritas | 59 | 55 | 59 | 59 | 60 | 63 | 59 |
| UL LLC | 54 | 57 | 57 | 61 | 65 | 68 | 60 |
| NSF International | 48 | 51 | 42 | 55 | 60 | 64 | 53 |
| Covance Inc. (LabCorp) | 44 | 48 | 46 | 48 | 52 | 56 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Eurofins Scientific
- SGS SA
- Intertek Group plc
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Eurofins Scientific | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| SGS SA | ✓ | − | ◐ | ◐ | ✓ | ✓ |
| Intertek Group plc | ✓ | ◐ | ◐ | ◐ | ✓ | ✓ |
| TÜV SÜD | − | − | ◐ | − | ◐ | ◐ |
| Bureau Veritas | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| UL LLC | ◐ | − | − | − | − | − |
| NSF International | − | − | − | ◐ | ◐ | ◐ |
| Covance Inc. (LabCorp) | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Eurofins Scientific80
2SGS SA75
3Intertek Group plc73
4TÜV SÜD69
5UL LLC60
6Bureau Veritas59
7NSF International53
8Covance Inc. (LabCorp)49
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Eurofins Scientific
Challenger3
Strong scale, closing on the leaders.
SGS SAIntertek Group plcTÜV SÜD
Contender2
Focused players with pockets of strength.
Bureau VeritasUL LLC
Niche2
Specialists in a single segment or region.
NSF InternationalCovance Inc. (LabCorp)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Device Type in North America, then scale across Medical Device Testing Market — a $121M beachhead inside a $1.91B market.
Beachhead (SOM)$121Mobtainable near-term
Serviceable (SAM)$736Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Cardiovascular Devices
Best fit — highest urgency & budget in Device Type.
Economic buyer79 fit
Orthopedic Devices
Strong fit — clear ROI and a fast path to value.
End user69 fit
Diagnostic Imaging Devices
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Device Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Testing Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel27%
Digital / self-serve20%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Device Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Medical Device Testing Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified25%
Evaluation14%
Closed-won5%
$10.3KCAC
$45KLTV
4.4:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Medical Device Testing Market is a high-growth opportunity — $4.68B by 2033, compounding at 11.4%.
TAM · 2025$1.97Btoday
TAM · 2033$4.68Bforecast
CAGR11.4%2027–2033
Cumulative$28.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.68BTotal addressable market
SAM$1.80BServiceable available market
SOM$314MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.4% CAGR
Demand compounds through 2033, outpacing GDP across Device Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Device Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.68BLarge & growingTAM by 2033 at 11.4% CAGR
$1.80BServiceable nowreachable with today’s model
$314MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.65BBear7.4% CAGR
$4.68BBase11.4% CAGR
$5.98BBull15.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Testing Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Medical Device Testing Market — a $6.51B market by 2033. Plan: grow share from 7.9% to 17.1%.
Market size · 2033$6.51Btotal addressable
Market CAGR3.3%2027–2033
Target share17.1%from 7.9% today
Revenue ambition$1.11Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.9% | 17.1% | On track |
| Revenue | $507M | $1.11B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 30.1% | 40.9% | On track |
| Customer retention | 85.5% | 96.0% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Device Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Testing Type capability
A defensible second engine — invest in Testing Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Device Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Testing Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $142M capacity & capability investment
- Greenlight bolt-on M&A in Testing Type
- Authorise North America expansion plan
- Fund R&D program for Device Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Medical Device Testing Market conversation — a $5.04B market you can size, segment and defend in minutes.
Market size · 2033$5.04Btotal opportunity
Growth10.0%CAGR to 2033
Addressable buyers1,239+accounts in scope
Typical ROI7.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Device Type
Goal Grow share in Device Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.5×return on cost, year one
< 2 mopayback period
$94K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Eurofins ScientificSGS SAIntertek Group plcTÜV SÜDBureau VeritasUL LLCNSF InternationalCovance Inc. (LabCorp)+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Medical Device Testing Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Medical Device Testing Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Amifostine for Injection Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportContinuous Glucose Monitoring Devices Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportAmifampridine Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportCardiac POC Testing Devices and Kits Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportOphthalmic Diagnostic Equipment Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportStructural Heart Disease Treatment Devices Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportImplantable Cardioverter Defibrillator Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportDisposable Trocars Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportAmide Local Anesthetics Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportElectronic Endoscopic Instruments Market
Market size, share, segmentation and regional forecast.
$366M market · 2025 base year
View reportPortable Gamma Cameras Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportPositive-displacement Dental Vacuum Pumps Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.